tirzepatide type 1 diabetes trial for diabetes: on track to SURPASS current therapy Efficacy and safety of tirzepatide

10.1038/nrc2228 Nat

Whilst this once-weekly injectable medication effectively lowers blood sugar and promotes weight loss, patients may wonder about potential side effects, including whether Ozempic causes hearing loss

Es una sustancia proaterognica que est asociada con riesgos de enfermedad cardiovascular

Weight loss during pregnancy is not recommended, and there are no adequate data on tirzepatide use in pregnant women or during breastfeeding

Not everyone qualifies due to their physical situation or insurance issues

We also learned these gastrointestinal symptoms were most intense during the dose escalation phases, and tended to diminish significantly with continued treatment at a stable dose